Related Experiment Video
Updated: Jul 13, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Malarial protease inhibitors: potential new chemotherapeutic agents
1Indian Council of Medical Research, National Institute of Malaria Research, 22 Sham Nath Marg, Delhi 110 054, India. sharmaa@icmr.org.in
Abstract:
The current limitations of malaria vaccine development, and the emergence and spread of insecticide-resistant vectors and drug-resistant parasites are major causes behind the re-emergence and severity of a worldwide malaria problem. A potential new target for antimalarial chemotherapy includes the malarial proteases that are required for erythrocytic invasion, egress and degradation of hemoglobin by parasites for its survival. Protease inhibitors must be highly potent and specific for parasite proteases to be recognized as biological tools. Screening, synthesis and evaluation studies have identified non-peptide derivatives that are able to kill parasites in vitro via protease inhibition. This review summarizes experimental evidence to support the rational design and development of protease inhibitors as potential new antimalarial drugs.
Related Concept Videos
Anthelminthic Agents
Antiprotozoal Agents
Malaria
Inhibitors of Virion Maturation and Assembly
Antifungal Agents
Inhibitors of Viral Protein Synthesis
